HF 3832 Minnesota House · 2025-2026 Regular Session

Definition of compounding of a drug amended to exempt the use of a flavoring agent.

This bill amends Minnesota's definition of drug compounding to explicitly exclude the use of flavoring agents. It directly affects pharmacists and healthcare providers who prepare customized medications for patients. The legislation adds a new definition for "flavoring agent" as a therapeutically inert substance used to improve a drug's taste and palatability. By clarifying that adding flavoring agents does not constitute compounding, the bill aims to distinguish between standard drug preparation and activities requiring special regulatory oversight. This change ensures that routine flavoring of medications remains outside the strict compounding regulations.
Bill status passed 3 of 5 stages cleared
Introduction
Mar 2026
Committee Review
Apr 2026
House Passage
Apr 2026
Senate Passage
Governor
Introduced Mar 2, 2026 Last action Apr 28, 2026
Floor votes · House Apr 27, 2026

How they voted

1330
Passed
Total votes 133
Apr 27, 2026
D Democratic66
66 Yea
100% Yea
R Republican67
67 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
9
Key actions
2
Committee
2
Apr 28, 2026
Committee
Referred to Health and Human Services
upper
Apr 28, 2026
Introduced
Introduction and first reading
upper
Apr 28, 2026
Introduced
Received from House
upper
Apr 27, 2026
Lower · Passed
Bill was passed
lower
Mar 12, 2026
Lower · Passed
Committee report, to adopt
lower
Mar 2, 2026
Introduced
Introduction and first reading, referred to Health Finance and Policy
lower
1 primary · 2 co-sponsors

Sponsors